<DOC>
	<DOCNO>NCT00006086</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness BMS-188797 carboplatin treat patient advanced nonhematologic cancer .</brief_summary>
	<brief_title>BMS-188797 Carboplatin Treating Patients With Advanced Nonhematologic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine recommend phase II dose base maximum tolerated dose BMS-188797 administer carboplatin patient advance nonhematologic malignancy . - Assess dose limit toxicity safety treatment regimen patient . - Determine plasma pharmacokinetics treatment regimen patient . - Determine antitumor activity treatment regimen patient . OUTLINE : This dose escalation study BMS-188797 . Patients receive BMS-188797 IV 1 hour follow carboplatin IV 30 minute day 1 . Treatment repeat every 21 day minimum 2 course absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos BMS-188797 maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 6 patient experience dose limit toxicity . Patients follow 4 week , every 3 month thereafter . PROJECTED ACCRUAL : Approximately 35 patient accrue study 12 month .</detailed_description>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm advanced nonhematologic malignancy progress standard therapy curative therapy exist No brain metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 3 month Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 mg/dL ALT AST great 2.5 time upper limit normal ( ULN ) unless due hepatic metastasis Renal : Creatinine great 1.5 time ULN Other : No chronic medical condition require treatment corticosteroid No prior severe hypersensitivity reaction agent contain Cremophor ( polyoxyethylated castor oil ) No serious uncontrolled medical disorder , active infection , psychiatric disorder ( e.g. , dementia ) would preclude study No preexist neurotoxicity grade 1 great Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover No concurrent immunotherapy Chemotherapy : At least 4 week since prior chemotherapy ( 6 week nitrosoureas mitomycin ) recover No 2 prior chemotherapy regimens metastatic disease No prior platinum taxane therapy No concurrent chemotherapy Endocrine therapy : At least 2 week since prior hormonal therapy ( except megestrol anorexia/cachexia ) recover At least 7 day since prior corticosteroid No concurrent corticosteroids No concurrent hormonal therapy Radiotherapy : At least 4 week since prior radiotherapy 30 % bone marrow recover No concurrent radiotherapy Surgery : Not specify Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>